{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:31:32Z","timestamp":1794670292854,"version":"4.9.1"},"reference-count":43,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,10,27]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Graft-versus-graft alloreactivity after dUCBT involves recognition of mismatched HLA class II alleles by allele-specific CD4+ effector T cells. Alloreactive donor CD4+ T cells may recognize recipient leukemia if mismatched for individual HLA class II alleles.<\/jats:p>","DOI":"10.1182\/blood-2016-06-718619","type":"journal-article","created":{"date-parts":[[2016,8,16]],"date-time":"2016-08-16T22:59:34Z","timestamp":1471388374000},"page":"2165-2174","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":36,"title":["CD4+ T-cell alloreactivity toward mismatched HLA class II alleles early after double umbilical cord blood transplantation"],"prefix":"10.1182","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6887-1377","authenticated-orcid":false,"given":"Cor H. J.","family":"Lamers","sequence":"first","affiliation":[{"name":"Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Wijers","sequence":"additional","affiliation":[{"name":"Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-4517","authenticated-orcid":false,"given":"Cornelis A. M.","family":"van Bergen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith A. E.","family":"Somers","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; and"},{"name":"Department of Transfusion Medicine, Sanquin Blood Supply, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Braakman","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Willem","family":"Gratama","sequence":"additional","affiliation":[{"name":"Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3649-807X","authenticated-orcid":false,"given":"Reno","family":"Debets","sequence":"additional","affiliation":[{"name":"Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9819-4813","authenticated-orcid":false,"given":"J. H. Frederik","family":"Falkenburg","sequence":"additional","affiliation":[{"name":"Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.","family":"Cornelissen","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111902401060400_B1","author":"Anasetti"},{"issue":"1","key":"2019111902401060400_B2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1182\/blood-2015-07-604546","article-title":"Hematopoietic stem cell transplantation for patients with AML in first complete remission.","volume":"127","author":"Cornelissen","year":"2016","journal-title":"Blood"},{"issue":"2","key":"2019111902401060400_B3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.seminhematol.2016.01.007","article-title":"Cord blood versus haploidentical stem cell transplantation for hematological malignancies.","volume":"53","author":"Kekre","year":"2016","journal-title":"Semin Hematol"},{"issue":"22","key":"2019111902401060400_B4","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1056\/NEJMoa041276","article-title":"Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.","volume":"351","author":"Laughlin","year":"2004","journal-title":"N Engl J Med"},{"issue":"22","key":"2019111902401060400_B5","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1056\/NEJMoa041469","article-title":"Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.","volume":"351","author":"Rocha","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111902401060400_B6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1182\/blood-2004-07-2717","article-title":"Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.","volume":"105","author":"Barker","year":"2005","journal-title":"Blood"},{"issue":"11","key":"2019111902401060400_B7","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3324\/haematol.2014.106690","article-title":"Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.","volume":"99","author":"Somers","year":"2014","journal-title":"Haematologica"},{"issue":"8","key":"2019111902401060400_B8","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood-2007-04-067215","article-title":"Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease.","volume":"110","author":"Brunstein","year":"2007","journal-title":"Blood"},{"issue":"1","key":"2019111902401060400_B9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.bbmt.2006.08.041","article-title":"Double unrelated reduced-intensity umbilical cord blood transplantation in adults.","volume":"13","author":"Ballen","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"2019111902401060400_B10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/sj.bmt.1705423","article-title":"Early engraftment kinetics of two units cord blood transplantation.","volume":"38","author":"Kang","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2019111902401060400_B11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2141.2009.07782.x","article-title":"Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications.","volume":"147","author":"Delaney","year":"2009","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111902401060400_B12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.coi.2006.07.015","article-title":"Double umbilical cord blood transplantation.","volume":"18","author":"Majhail","year":"2006","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"2019111902401060400_B13","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1182\/blood-2010-08-300491","article-title":"Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts.","volume":"117","author":"Avery","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2019111902401060400_B14","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/bmt.2011.184","article-title":"Factors predicting single-unit predominance after double umbilical cord blood transplantation.","volume":"47","author":"Ramirez","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2019111902401060400_B15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1182\/blood-2009-07-228999","article-title":"Single-unit dominance after double-unit umbilical cord blood transplantation coincides with a specific CD8+ T-cell response against the nonengrafted unit.","volume":"115","author":"Gutman","year":"2010","journal-title":"Blood"},{"issue":"2","key":"2019111902401060400_B16","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.bbmt.2012.09.022","article-title":"Double umbilical cord blood transplantation: a study of early engraftment kinetics in leukocyte subsets using HLA-specific monoclonal antibodies.","volume":"19","author":"Somers","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2019111902401060400_B17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.humimm.2004.01.003","article-title":"Umbilical cord blood-naive T cells but not adult blood-naive T cells require HLA class II on antigen-presenting cells for allo-immune activation.","volume":"65","author":"Kloosterboer","year":"2004","journal-title":"Hum Immunol"},{"issue":"2","key":"2019111902401060400_B18","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/sj.leu.2401953","article-title":"Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers.","volume":"15","author":"Thiede","year":"2001","journal-title":"Leukemia"},{"issue":"1","key":"2019111902401060400_B19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbmt.2012.07.020","article-title":"Patient HLA-DP-specific CD4+ T cells from HLA-DPB1-mismatched donor lymphocyte infusion can induce graft-versus-leukemia reactivity in the presence or absence of graft-versus-host disease.","volume":"19","author":"Rutten","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2019111902401060400_B20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1182\/blood-2010-07-294520","article-title":"Immune responses to transgene and retroviral vector in patients treated with ex vivo-engineered T cells.","volume":"117","author":"Lamers","year":"2011","journal-title":"Blood"},{"issue":"11","key":"2019111902401060400_B21","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.bbmt.2015.07.015","article-title":"Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.","volume":"21","author":"Purtill","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"2019111902401060400_B22","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.bbmt.2010.03.018","article-title":"HLA-DPB1 mismatching results in the generation of a full repertoire of HLA-DPB1-specific CD4+ T cell responses showing immunogenicity of all HLA-DPB1 alleles.","volume":"16","author":"Rutten","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2019111902401060400_B23","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.4049\/jimmunol.0903655","article-title":"Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity.","volume":"184","author":"Sidney","year":"2010","journal-title":"J Immunol"},{"issue":"6","key":"2019111902401060400_B24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/ejh.12283","article-title":"Na\u00efve subset develops the most important alloreactive response among human CD4+ T lymphocytes in human leukocyte antigen-identical related setting.","volume":"92","author":"Ch\u00e9rel","year":"2014","journal-title":"Eur J Haematol"},{"issue":"7","key":"2019111902401060400_B25","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.3324\/haematol.2010.037481","article-title":"Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.","volume":"96","author":"Distler","year":"2011","journal-title":"Haematologica"},{"issue":"7","key":"2019111902401060400_B26","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.bbmt.2011.12.586","article-title":"In vitro evaluation of graft-versus-graft alloreactivity as a tool to identify the predominant cord blood unit before double cord blood transplantation.","volume":"18","author":"Moretta","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"2019111902401060400_B27","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.bbmt.2012.01.014","article-title":"Early CD3 peripheral blood chimerism predicts the long-term engrafting unit following myeloablative double-cord blood transplantation.","volume":"18","author":"Newell","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"19","key":"2019111902401060400_B28","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1182\/blood-2010-03-276212","article-title":"An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.","volume":"116","author":"Eldjerou","year":"2010","journal-title":"Blood"},{"issue":"8","key":"2019111902401060400_B29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.bbmt.2010.03.010","article-title":"A preclinical model of double- versus single-unit unrelated cord blood transplantation.","volume":"16","author":"Georges","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2019111902401060400_B30","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1470-2045(10)70127-3","article-title":"Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis.","volume":"11","author":"Eapen","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"2019111902401060400_B31","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3324\/haematol.2013.094193","article-title":"Unrelated umbilical cord blood transplant for adult acute lymphoblastic leukemia in first and second complete remission: a comparison with allografts from adult unrelated donors.","volume":"99","author":"Marks","year":"2014","journal-title":"Haematologica"},{"issue":"10","key":"2019111902401060400_B32","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/ajh.24112","article-title":"Impact of the source of hematopoietic stem cell in unrelated transplants: comparison between 10\/10, 9\/10-HLA matched donors and cord blood.","volume":"90","author":"Granier","year":"2015","journal-title":"Am J Hematol"},{"issue":"9","key":"2019111902401060400_B33","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/leu.2015.98","article-title":"Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia.","volume":"29","author":"Ruggeri","year":"2015","journal-title":"Leukemia"},{"issue":"18","key":"2019111902401060400_B34","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1405584","article-title":"One-unit versus two-unit cord-blood transplantation for hematologic cancers.","volume":"371","author":"Wagner","year":"2014","journal-title":"N Engl J Med"},{"issue":"11","key":"2019111902401060400_B35","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1016\/j.bbmt.2015.07.029","article-title":"High Disease-Free Survival with Enhanced Protection against Relapse after Double-Unit Cord Blood Transplantation When Compared with T Cell-Depleted Unrelated Donor Transplantation in Patients with Acute Leukemia and Chronic Myelogenous Leukemia.","volume":"21","author":"Ponce","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"22","key":"2019111902401060400_B36","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/blood-2010-05-285304","article-title":"Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood.","volume":"116","author":"Brunstein","year":"2010","journal-title":"Blood"},{"issue":"7","key":"2019111902401060400_B37","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/bmt.2011.195","article-title":"Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies.","volume":"47","author":"Kindwall-Keller","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"2019111902401060400_B38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.bbmt.2015.09.025","article-title":"Impact of allele-level HLA mismatch on outcomes in recipients of double umbilical cord blood transplantation.","volume":"22","author":"Brunstein","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"26","key":"2019111902401060400_B39","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1182\/blood-2016-01-694349","article-title":"Single- vs double-unit cord blood transplantation for children and young adults with acute leukemia or myelodysplastic syndrome.","volume":"127","author":"Michel","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2019111902401060400_B40","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.leu.2402865","article-title":"HLA-DR antigen-negative acute myeloid leukemia.","volume":"17","author":"Wetzler","year":"2003","journal-title":"Leukemia"},{"issue":"13","key":"2019111902401060400_B41","first-page":"1\/1\/13","article-title":"Immune evasion in acute myeloid leukemia: current concepts and future directions.","volume":"1","author":"Teague","year":"2013","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2019111902401060400_B42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1756-8722-6-74","article-title":"The role of PD-1 and PD-L1 in T-cell immune suppression in patients with hematological malignancies.","volume":"6","author":"Shi","year":"2013","journal-title":"J Hematol Oncol"},{"issue":"2","key":"2019111902401060400_B43","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/leu.2011.222","article-title":"Human allo-reactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD\/scid mice engrafted with human acute lymphoblastic leukemia.","volume":"26","author":"Stevanovi\u0107","year":"2012","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/17\/2165\/1396487\/2165.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/128\/17\/2165\/1396487\/2165.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:41:39Z","timestamp":1574131299000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/128\/17\/2165\/35590\/CD4-Tcell-alloreactivity-toward-mismatched-HLA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,27]]},"references-count":43,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2016,10,27]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2016-06-718619","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,27]]}}}